Carregant...

A Transient Increase in Eosinophils is Associated with Prolonged Survival in Men with Metastatic Castration-Resistant Prostate Cancer Who Receive Sipuleucel-T

Sipuleucel-T is an autologous cellular immunotherapy used to treat asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Traditional short-term indicators of clinical response commonly used with chemotherapy have not correlated with survival in patients treat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: McNeel, Douglas G., Gardner, Thomas A., Higano, Celestia S., Kantoff, Philip W., Small, Eric J., Wener, Mark H., Sims, Robert B., DeVries, Todd, Sheikh, Nadeem A., Dreicer, Robert
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185225/
https://ncbi.nlm.nih.gov/pubmed/25189164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-14-0073
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!